It was recently announced that AstraZeneca is now in agreement - TopicsExpress



          

It was recently announced that AstraZeneca is now in agreement with the Max Planck Institute of Molecular Physiology (MPI), Germany, to establish a ‘satellite unit’ in cardiovascular and metabolic disease (CVMD), linked to AstraZeneca’s CVMD Innovative Medicines unit (iMed) in Molndal, Sweden to study new modalities chemistry. Learn more here: astrazeneca/Research/news/Article/20140708-astrazeneca-and-max-planck-institute-announce-research-agreement
Posted on: Thu, 31 Jul 2014 15:00:33 +0000

Trending Topics



Recently Viewed Topics




© 2015